Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiming Granules and Keluoxin Capsules for diabetic eye and kidney microvascular disease
ChiCTR-IPR-17012972Phase 4Recruiting
- Sponsor
- Gansu Provincial Hospital of Traditional Chinese Medicine
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of qiming granule and Keluoxin in diabetic retinopathy (DR), diabetic glomerulosclerosis and diabetic microangiopathy (3 arms), sponsored by Gansu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Renal function, Ophthalmic routine examination and 4 more. Started May 2017; status: recruiting.
02
Drugs
qiming granuleKeluoxin
03
Conditions
diabetic retinopathy (DR)diabetic glomerulosclerosisdiabetic microangiopathy
Beyond the preview
Go deeper on ChiCTR-IPR-17012972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012972.